Click here to read about the QuanTyper™-48 HRM Early-Access Program 2008
We are currently offering the Early-Access program to customers in selected markets. Select your country to see if you can take part in the program.
The PCR process is covered by several patents owned by Roche Molecular Systems and F.Hoffman-La Roche Limited.
